M-Corps Showcase with CUBRC and Clinical Research Strategies

PART 1
1:00-1:30 PM ET
CUBRC: “Partnering with CUBRC: A Strategic Path to Non-Dilutive Funding for Medical Product Development.”

Our goal for this webinar is to familiarize the MTEC community with CUBRC and our capabilities and offerings in medical countermeasure development and biological defense RDT&E.

CUBRC works with drug, diagnostic, medical device, and vaccine developers to secure US Government funding for activities spanning the development pipeline including lead identification and optimization, early preclinical development, IND enabling studies, and clinical studies. CUBRC operates as a systems integrator and prime contractor applying our deep expertise managing complex government-funded science and technology programs. This reduces risk for our partners and for the government, which increases the likelihood of award and successful execution of contracts aimed at the development of therapeutics and vaccines for use against traditional public health diseases as well as for indications associated with the use of biological, chemical, or radiological weapons.

In addition to working as a systems integrator on pharmaceutical development programs, CUBRC supports our partners by providing BSL-2 and BSL-3 laboratory-based research, development, testing and evaluation (RDT&E). In particular, we support drug, device, and diagnostic development by assessing the effectiveness of these products in our laboratories using a variety of in vitro assays with multiple public health and biological threat agents.

Speaker: Katie Edwards, Ph.D., Director, Biological and Medical Sciences, CUBRC, Inc

PART 2
1:30-2:00 PM ET
Critical Research Strategies: "Case Studies in Building Clinical Evidence for Attracting Funding or Strategics.”

Entrepreneurs and academics alike face challenges with how to spend their limited funds to obtain their biggest wins to attract investment, non-dilutive funding, or business strategics. This webinar will highlight case studies of the dilemmas faced and decisions made by company officials to move programs forward and publish clinical evidence necessary to garner attraction and interest.

Speaker: Alethea Wieland, Founder and CEO, Critical Research Strategies, LLC

Register at: https://ati.zoomgov.com/meeting/register/mYh8mF8bRjSmJ_KtXuT5cA

**You must be current MTEC or CWMD/MCDC Member in good standing in order to attend**